An upstream reproductive-hormone signal — no lawful §503A pathway at RE GEN today.
Oswego, Illinois · 74 W. Washington St · serving the Fox Valley. A licensed Illinois clinician still decides. Compounded medications are not FDA-approved.
Legal status reviewed July 2026 · As needed per protocol
What is Kisspeptin?
The molecule, in plain language.
Kisspeptin is a neuropeptide that sits upstream of GnRH. It is scientifically interesting for reproductive endocrinology. Interest is not a compounding basis. RE GEN will not request it until a documented lawful pathway exists.
How people usually take it. Not orderable. There is no RE GEN vial, capsule, or nasal spray for kisspeptin today.
What people are actually trying to solve.
Interest is not a result. We keep the research language and skip the miracle.
01
Why people ask
Kisspeptin research is about the brain’s reproductive pulse generator. That is a real scientific story. It is not a product we can send.
·Neuropeptide signaling
·Not interchangeable with gonadorelin
·Not a fertility guarantee in any case
02
What we can discuss instead
Hormone visits can still cover TRT-support tools that do have a pathway, when a clinician decides they fit.
·Gonadorelin
·hCG
·A full hormone evaluation
03
How RE GEN handles “no”
Peptide credibility is saying no on the same page that explains the science.
·No research-chemical workaround
·No “ask the pharmacy anyway”
·Status can change if FDA creates a basis
What the evidence actually is — and what it isn’t.
A note on honesty: we will tell you what the literature supports and what it does not. Animal data is not a human guarantee. Anecdotes are not trials.
Animal research
Kisspeptin literature includes substantial animal work on GnRH pulse generation and reproductive onset.
·Upstream reproductive signaling
·Does not create a 503A basis
·Animal data is not a clinic vial
Human research
Human research exists in reproductive endocrinology. That still does not make it compoundable at RE GEN today.
·Limited as a compounding conversation
·Not orderable
·Do not buy “research” kisspeptin online
Legal basis at RE GEN · July 2026
We will not compound this today.
No lawful §503A pathway at this time. Not nominated / no bulk-eligibility we can use. We will not compound kisspeptin.
We will not compound this. Ask us what is carried instead.
Peptide education for Illinois patients at RE GEN in Oswego — not a substitute for a visit.
What is kisspeptin?
A neuropeptide that helps trigger GnRH release. Scientifically interesting. Not orderable at RE GEN today.
Is kisspeptin FDA-approved?
kisspeptin is not FDA-approved, and RE GEN does not have a lawful §503A pathway to request it as a compounded medication today. A committee vote is not approval.
Can I get kisspeptin at RE GEN in Oswego?
You can start a visit to talk about your goal. We will not compound kisspeptin today. We will show you what is carried instead — and we will say no rather than gray-market a vial.
Can I bring my own vial?
No. We do not inject or supervise gray-market peptides. Start a visit to talk about what is carried.
Do you promise results?
No. Educational pages explain why people ask and what the research landscape looks like. Individual response varies. Compounded medications are not FDA-approved, and a request is not a guaranteed prescription.